Quantitative oropharyngeal Epstein-Barr virus shedding in renal and cardiac transplant recipients: relationship to immunosuppressive therapy, serologic responses, and the risk of posttransplant lymphoproliferative disorder.
about
Serological diagnosis of Epstein-Barr virus infection: Problems and solutionsEpstein-Barr virus infection and posttransplant lymphoproliferative disorderPsychotic symptoms and confusion associated with intravenous ganciclovir in a heart transplant recipientInfection in Organ Transplantation.Infectious and tropical diseases affecting the human mouth.Epstein-Barr virus latent infection in vivo.The role of EBV in post-transplant malignancies: a review.Normalized quantification by real-time PCR of Epstein-Barr virus load in patients at risk for posttransplant lymphoproliferative disordersDetection of Epstein-Barr virus DNA in sera from transplant recipients with lymphoproliferative disorders.Epidemiology of infections after solid-organ transplantation.Diagnosis and management of posttransplant lymphoproliferative disorder in solid-organ transplant recipients.Epstein-Barr virus load monitoring: its role in the prevention and management of post-transplant lymphoproliferative disease.Infection in solid organ transplantation.Use of quantitative competitive PCR to measure Epstein-Barr virus genome load in the peripheral blood of pediatric transplant patients with lymphoproliferative disorders.Molecular parameters for precise diagnosis of asymptomatic Epstein-Barr virus reactivation in healthy carriersIncreased presence of Epstein-Barr virus DNA in ocular fluid samples from HIV negative immunocompromised patients with uveitis.Infections in solid-organ transplant recipientsEpstein-Barr virus latent membrane protein 2 associates with and is a substrate for mitogen-activated protein kinase.Epstein-Barr virus infection in transplant recipients: Summary of a workshop on surveillance, prevention and treatmentLongitudinal analysis of frequency and reactivity of Epstein-Barr virus-specific T lymphocytes and their association with intermittent viral reactivation.Epstein-Barr virus and posttransplant lymphoproliferative disorder in solid organ transplantation.Development of monoclonal gammopathy precedes the development of Epstein-Barr virus-induced posttransplant lymphoproliferative disorder.Oligo-monoclonal immunoglobulins frequently develop during concurrent cytomegalovirus (CMV) and Epstein-Barr virus (EBV) infections in patients after renal transplantation.Epidemiology and morbidity of Epstein-Barr virus infection in pediatric renal transplant recipients: a multicenter, prospective study.OKT3 and ganciclovir treatments are possibly related to the presence of Epstein-Barr virus in serum after liver transplantation.Measurement by the polymerase chain reaction of the Epstein-Barr virus load in infectious mononucleosis and AIDS-related non-Hodgkin's lymphomas.B non-Hodgkin's lymphoma in a haemophilia patient with idiopathic CD4+ T-lymphocytopenia.
P2860
Q26829346-65263BE0-CA1C-47DD-A14E-329E3D100A6EQ27024229-E16C11C1-4540-4A35-B4EE-B2804C1C9FA0Q28377161-6EC15DB1-8177-45BF-8819-4782190E2F50Q30238810-80E1F57B-B98F-40C2-B3A8-70E8C062AEC4Q33592369-844E628E-24C2-421E-8CCF-C3843B0A1179Q33682952-2CF7D268-56A4-478C-A07F-83E5999A6285Q33925488-59838C2E-716B-468E-BDB2-F85368AF8B0DQ33971192-E1DD407C-B1EE-4DD8-926B-5CB3D6129B48Q33974645-DFE920AA-3D62-4D57-A984-24D4977843D8Q34271651-24755E8F-53A5-4C20-BFB0-5DA422219E0BQ34271690-126D8549-6DD0-4AC8-8396-627CF8A16792Q34275907-5A1910C9-BDEC-4737-8E1D-FBEEAC091EB4Q34294779-A634D96E-62C3-4C6F-B08B-26FAF503E328Q34427085-5088DD6A-EDCC-4F4D-B03A-3F44EEFA2B00Q34948319-73DDE78A-7D52-4CEB-92FB-A63667637DEDQ35304254-80EF9EF5-E0CD-4366-B83F-70F382E796C3Q35376486-43A57C6E-58C7-4B15-8CB2-B1F0A6324978Q35887119-289122DF-9065-4CC3-9B37-0C22C88BFC10Q36170494-F19EEAA9-25CE-4BFB-A207-0CA73E87B788Q39441043-F4AF359D-EC7A-4E00-9B60-8FAF81719630Q42272334-3A12F431-E826-463B-86DE-E954AE0267A4Q43690916-CAC10156-1DAE-4C69-A83A-FB4C12B41B1FQ44032290-5DFAB838-CB27-48A1-93B3-8F688A532664Q44061780-E0C6A2A7-D4F6-4158-B5EE-2665FF8EABF2Q45450388-C3146771-24DB-4805-968B-3500A063EE93Q45787831-F045E599-930B-4658-87A8-6FA72D9A88DEQ45879527-4AE55025-B158-4CD7-9A35-D6DE180EDDDE
P2860
Quantitative oropharyngeal Epstein-Barr virus shedding in renal and cardiac transplant recipients: relationship to immunosuppressive therapy, serologic responses, and the risk of posttransplant lymphoproliferative disorder.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年学术文章
@wuu
1992年学术文章
@zh-cn
1992年学术文章
@zh-hans
1992年学术文章
@zh-my
1992年学术文章
@zh-sg
1992年學術文章
@yue
1992年學術文章
@zh
1992年學術文章
@zh-hant
name
Quantitative oropharyngeal Eps ...... lymphoproliferative disorder.
@en
Quantitative oropharyngeal Eps ...... lymphoproliferative disorder.
@nl
type
label
Quantitative oropharyngeal Eps ...... lymphoproliferative disorder.
@en
Quantitative oropharyngeal Eps ...... lymphoproliferative disorder.
@nl
prefLabel
Quantitative oropharyngeal Eps ...... lymphoproliferative disorder.
@en
Quantitative oropharyngeal Eps ...... lymphoproliferative disorder.
@nl
P2093
P356
P1476
Quantitative oropharyngeal Eps ...... lymphoproliferative disorder.
@en
P2093
Diaz-Mitoma F
Mirzayans F
Preiksaitis JK
Tyrrell DL
P304
P356
10.1093/INFDIS/166.5.986
P407
P577
1992-11-01T00:00:00Z